In this section, you’ll find important information and resources gathered by MPE during the COVID-19 (coronavirus) outbreak. Myeloma Patients Europe is committed to ensuring that you have access to the latest information regarding COVID-19 and how it affects myeloma patients and their treatments.
The following are the latest publications MPE has developed regarding COVID-19 and COVID-19 vaccinations.
- Assessment of the needs of patient organisations during the COVID-19 pandemic
- The impact of the COVID-19 pandemic on the healthcare and lives of people with myeloma or AL amyloidosis and their caregivers
- Q&A on SARS-CoV-2 (COVID-19) Vaccination for Myeloma Patients
- Webinar COVID-19 vaccines for myeloma patients: what you need to know
Further below, you can read MPE’s publications, discover tips for patients and find global and national COVID-19 information.
